Key facts
- Invus Global Management, LLC filed SCHEDULE 13G/A for Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB).
- Disclosed ownership: 9.6%.
- Date of event: 31 Mar 2025.
Invus Global Management, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB)
- Filing Manager
- Invus Global Management, LLC
- Reporting Manager
- Raymond Debbane
- Symbol
- SLDB
- Shares outstanding
- 77,249,010 shares
- Disclosed Ownership
- 7,415,905 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Apr 2025, 18:50:50 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 12 Feb 2025
- SEC
- View on sec.gov
Key filing fact
Invus Global Management, LLC disclosed 9.6% ownership in Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB) on 31 Mar 2025.
Change
- Previous schedule filing date: 12 Feb 2025.
- Current filing was accepted on 17 Apr 2025, 18:50.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (8)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 8.3% | 6,402,653 | 6,402,653 | 0 | /s/ Raymond Debbane | Raymond Debbane, President, Invus Public Equities Advisors, LLC, its general partner | |
| Invus Public Equities Advisors, LLC | 8.3% | 6,402,653 | 6,402,653 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Invus Global Management, LLC | 8.3% | 6,402,653 | 6,402,653 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Siren, L.L.C. | 8.3% | 6,402,653 | 6,402,653 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Avicenna Life Sci Master Fund LP | 1.3% | 1,013,252 | 1,013,252 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer, Avicenna Life Sci Master GP LLC, its general partner | |
| Avicenna Life Sci Master GP LLC | 1.3% | 1,013,252 | 1,013,252 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer | |
| Ulys, L.L.C. | 1.3% | 1,013,252 | 1,013,252 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Raymond Debbane | 9.6% | 7,415,905 | 7,415,905 | 0 | /s/ Raymond Debbane | Raymond Debbane, |
CIK / CUSIP context first